a 41-Year-Old Female Patient with Drug-Induced Hypersensitivity Syndrome (DIHS) Caused by Antibiotics
DOI:
https://doi.org/10.53089/medula.v15i2.1619Keywords:
Drug Hypersensitivity Syndrome, Antibiotics, Allergic drug eruptionAbstract
Aberrant reactions to drugs vary, ranging from mild to severe clinical symptoms. Drug Hypersensitivity Syndrome (SHO) is a systemic autoimmune disorder caused by aberrant reactions to drugs which can cause symptoms in the form of skin eruptions, fever accompanied by involvement of one or several internal organs. Drug Hypersensitivity Syndrome is often caused by drugs such as trimethoprim, allopurinol, metronidazole, dapsone and abacavir. This disease can also occur due to cross-reaction of drugs, such as anti-convulsant drugs (carbamazepine, phenytoin, phenobarbital) and non-steroidal anti-inflammatory drugs (piroxicam). Reported on a 41 year old female patient with complaints including: the main complaint was red spots accompanied by itching all over the body and yellowing of both eyes. Clinical symptoms appeared after the patient consumed various types of drugs in the last two weeks. Investigation revealed thrombocytopenia and a drastic increase in liver enzymes. Based on the physical and supporting examination, a diagnosis of Drug Hypersensitivity Syndrome et causa susp was made. amoxicillin. The main management of SHO is identification and stopping the causative drug, symptomatic therapy and recommended administration of systemic corticosteroids.
References
Wei BM, Fox LP, Kaffenberger BH, et al. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management. J Am Acad Dermatol. 2024;90(5):911-926. doi:10.1016/j.jaad.2023.02.073
Loo CH, Tan WC, Khor YH, Chan LC. A 10-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia. Med J Malaysia. 2018;73(2):73-77.
Phillips EJ, Chung WH, Mockenhaupt M, Roujeau JC, Mallal SA. Drug hypersensitivity: pharmacogenetics and clinical syndromes. J Allergy Clin Immunol. 2011;127(3 Suppl):S60-S66. doi:10.1016/j.jaci.2010.11.046
Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol. 2010;146(12):1373-1379. doi:10.1001/archdermatol.2010.198
Damayanti, Anggraeni S, Rosita C, Hutomo M, Sukanto H. Studi Epidemiologi: Erupsi Obat Berat. Jurnal Unair Berkala Ilmu Kesehatan Kulit dan Kelamin. 2017;29(2):151-152
Singh T, Niazi M, Karri K, Rudikoff D, Gonzalez E. A Rare Case of DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Syndrome with Cholecystitis in a Patient on Levetiracetam. Cureus. 2019 Mar 13;11(3):e4245. doi: 10.7759/cureus.4245. PMID: 31131168; PMCID: PMC6516625.
Hama N, Abe R, Gibson A, Phillips EJ. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis. J Allergy Clin Immunol Pract. 2022;10(5):1155-1167.e5. doi:10.1016/j.jaip.2022.02.004
Martinez-Cabriales SA, Shear NH, Gonzalez-Moreno EI. Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome. World J Clin Cases. 2019 Mar 26;7(6):705-716. doi: 10.12998/wjcc.v7.i6.705. PMID: 30968035; PMCID: PMC6448072.
Wolfson AR, Zhou L, Li Y, Phadke NA, Chow OA, Blumenthal KG. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module. J Allergy Clin Immunol Pract. 2019;7(2):633-640. doi:10.1016/j.jaip.2018.08.013
Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol. 2021 Mar;77(3):275-289. doi: 10.1007/s00228-020-03005-9. Epub 2020 Oct 6. PMID: 33025080; PMCID: PMC7537982.
Emma Littlehales, Odhrán Murray, Robert Dunsmuir, "Vancomycin-Induced DRESS Syndrome: An Important Concern in Orthopedic Surgery", Case Reports in Orthopedics, vol. 2018, Article ID 1439073, 5 pages, 2018. https://doi.org/10.1155/2018/1439073
Hama N, Abe R, Gibson A, Phillips EJ. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis. J Allergy Clin Immunol Pract. 2022 May;10(5):1155-1167.e5. doi: 10.1016/j.jaip.2022.02.004. Epub 2022 Feb 15. PMID: 35176506; PMCID: PMC9201940.
Chen CB, Hung WK, Wang CW, Lee CC, Hung SI, Chung WH. Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review. Front Med (Lausanne). 2023 Jun 29;10:1187937. doi: 10.3389/fmed.2023.1187937. PMID: 37457584; PMCID: PMC10338933.
Cardones AR. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Clin Dermatol. 2020;38(6):702-711. doi:10.1016/j.clindermatol.2020.06.008
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
